Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1053 of 1,261
  1. US 7414140

    Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  2. US 7414037

    Hydrazide-containing CFTR inhibitor compounds and uses thereof

    The Regents of the University of California · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  3. US 7414035

    hKIS composition and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  4. US 7413864

    Treating cancer using a telomerase vaccine

    The Regents of the University of Colorado · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  5. US 7413781

    Gels for encapsulation of biological materials

    The Board of Regents of the University of Texas System · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  6. US 7413538

    Epitopes formed by non-covalent association of conjugates

    Mozaic Discovery Limited · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  7. US 7413870

    SAK: modulation of cellular proliferation for treatment of cancer

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  8. US 7414039

    Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis

    The Regents of the University of California · Granted Aug 19, 2008 · Expires Aug 14, 2028

    granted
  9. CA 2677623

    FORME PHARMACEUTIQUE CONTENANT DEUX OU DAVANTAGE DE PRINCIPES ACTIFS PHARMACEUTIQUES SOUS DES FORMES PHYSIQUES DIFFERENTES

    ALPHAPHARM PTY LTD [AU] · Granted Aug 14, 2008 · Expires Aug 9, 2028

    granted
  10. US 7410644

    Recombinant pox virus for immunization against tumor-associated antigens

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  11. US 7410758

    Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN

    The Board of Regents of the University of Texas System · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  12. US 7410665

    Coated implantable medical device

    Cook Regentec LLC · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  13. US 7410641

    Antibodies to insulin/IGF/relaxin family polypeptides

    Takeda Pharmaceutical Company Limited · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  14. US 7410363

    Electrical connector having compliant biasing device

    Hon Hai Precision Ind. Co., Ltd. · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  15. US 7410771

    Reagent and method for detecting a Cryptosporidium parvum sporozoite antigen

    The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  16. US 7411076

    Coumarin derivative

    Institute of Medicinal Molecular Design, Inc. · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  17. US 7410981

    Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers

    Takeda Pharmaceutical Company Limited · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  18. US 7410781

    IL-4/IL-13 specific polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  19. US 7410956

    Caspase inhibitor prodrugs

    Vertex Pharmaceuticals Incorporated · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  20. US 7410776

    Polypeptides, their production and use

    Takeda Pharmaceutical Company Limited · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  21. US 7411067

    Crystalline forms of gatifloxacin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  22. US 7410978

    Once daily dosage forms of trospium

    Supernus Pharmaceuticals, Inc. · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  23. US 7410958

    Triterpene quaternary salts as biologically active surfactants

    Regents of the University of Minnesota · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted
  24. US 7410979

    Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections

    Rigel Pharmaceuticals, Inc. · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.